Suara.com – Head of the National Research and Innovation Agency (BRIN) Laksana Tri Handoko said the Red and White vaccine could be used as a “booster” and regular vaccination of the COVID-19 vaccine.
“All vaccines, anything, can be used for boosters or regular vaccinations. The important thing is that they exist and are available first,” said Laksana Friday (12/3/2021).
He said the challenge for researchers in developing vaccines in general is not easy because it takes a lot of trials to get the most optimal formula to get vaccine seeds.
The vaccine seeds must also have a Good Manufacturing Practice (GMP) standard according to regulations.
Also Read: Red and White Vaccines Need Additional Clinical Trials As Boosters, Head of BPOM: Soon
According to him, the industry in the country is ready for the development and production of new vaccines with two platforms, namely based on an inactivated virus and recombinant protein.
Currently, the fastest progress on the development of the Merah Putih vaccine is being carried out by a team from Airlangga University (Unair) Surabaya in collaboration with PT Biotis, and a team from the Eijkman Institute for Molecular Biology in collaboration with PT Bio Farma.
“Eijkman developed a vaccine seed platform based on recombinant protein sub-units, while Unair developed a virus-based vaccine seed that was killed or inactivated,” he said.
His party emphasized that the main target of developing the Red and White vaccine was not to “win” the efficacy, because as long as it meets the standards of the World Health Organization (WHO), namely efficacy above 50 percent, the vaccine can already be used, said Laksana Tri Handoko. [Antara]
Also Read: BRIN Ready to Build Health Research Organization
Source: Suara.com – Berita Kesehatan Terkini by www.suara.com.
*The article has been translated based on the content of Suara.com – Berita Kesehatan Terkini by www.suara.com. If there is any problem regarding the content, copyright, please leave a report below the article. We will try to process as quickly as possible to protect the rights of the author. Thank you very much!
*We just want readers to access information more quickly and easily with other multilingual content, instead of information only available in a certain language.
*We always respect the copyright of the content of the author and always include the original link of the source article.If the author disagrees, just leave the report below the article, the article will be edited or deleted at the request of the author. Thanks very much! Best regards!